HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mutational signature of aristolochic acid exposure as revealed by whole-exome sequencing.

Abstract
In humans, exposure to aristolochic acid (AA) is associated with urothelial carcinoma of the upper urinary tract (UTUC). Exome sequencing of UTUCs from 19 individuals with documented exposure to AA revealed a remarkably large number of somatic mutations and an unusual mutational signature attributable to AA. Most of the mutations (72%) in these tumors were A:T-to-T:A transversions, located predominantly on the nontranscribed strand, with a strong preference for deoxyadenosine in a consensus sequence (T/CAG). This trinucleotide motif overlaps the canonical splice acceptor site, possibly accounting for the excess of splice site mutations observed in these tumors. The AA mutational fingerprint was found frequently in oncogenes and tumor suppressor genes in AA-associated UTUC. The AA mutational signature was observed in one patient's tumor from a UTUC cohort without previous indication of AA exposure. Together, these results directly link an established environmental mutagen to cancer through genome-wide sequencing and highlight its power to reveal individual exposure to carcinogens.
AuthorsMargaret L Hoang, Chung-Hsin Chen, Viktoriya S Sidorenko, Jian He, Kathleen G Dickman, Byeong Hwa Yun, Masaaki Moriya, Noushin Niknafs, Christopher Douville, Rachel Karchin, Robert J Turesky, Yeong-Shiau Pu, Bert Vogelstein, Nickolas Papadopoulos, Arthur P Grollman, Kenneth W Kinzler, Thomas A Rosenquist
JournalScience translational medicine (Sci Transl Med) Vol. 5 Issue 197 Pg. 197ra102 (Aug 07 2013) ISSN: 1946-6242 [Electronic] United States
PMID23926200 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Aristolochic Acids
  • aristolochic acid I
Topics
  • Aged
  • Aristolochic Acids (adverse effects)
  • Exome (genetics)
  • Female
  • Humans
  • Male
  • Middle Aged
  • Mutation (drug effects, genetics)
  • Sequence Analysis, DNA
  • Urologic Neoplasms (diagnosis, genetics, pathology)
  • Urothelium (pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: